Sign in

CIK 0001104506

  • Large accelerated filer
Ticker
INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
EIN
541972729
Phone
+1 908-977-9900
Business address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,100,000
in 1 filing

Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Brennan David R −$3.1M Director sold 39% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-02 Lewis William Chair and CEO Sale 10b5-1 −1,430 $71.94 $103K 233,924
2025-06-02 Lewis William Chair and CEO Exercise or conversion · Stock Option (right to buy) 10b5-1 −6,830 157,160
2025-05-30 Smith Michael Alexander Chief Legal Officer Sale 10b5-1 −6,327 $68.56 $434K 91,045
2025-05-30 Smith Michael Alexander Chief Legal Officer Sale 10b5-1 −20,000 $70.00 $1.4M 71,045
2025-05-27 SHAROKY MELVIN MD Director Gift −200 300,616
2025-05-21 Desjardins Clarissa Director Purchase +1,130 $66.35 $75K 3,025
2025-05-20 SHAROKY MELVIN MD Director Gift −400 300,816
2025-05-20 SHAROKY MELVIN MD Director Gift +100 100
2025-05-20 SHAROKY MELVIN MD Director Gift +100 100
2025-05-20 SHAROKY MELVIN MD Director Gift +100 100
2025-05-20 SHAROKY MELVIN MD Director Gift +100 100
2025-05-20 Desjardins Clarissa Director Purchase +1,895 $66.87 $127K 1,895
2025-05-20 Lewis William Chair and CEO Sale 10b5-1 −9,489 $66.87 $635K 325,798
2025-05-20 Lewis William Chair and CEO Sale 10b5-1 −4,480 $67.96 $304K 321,318
2025-05-20 Lewis William Chair and CEO Sale 10b5-1 −7,088 $68.49 $485K 314,230
2025-05-20 Lewis William Chair and CEO Exercise or conversion 10b5-1 +6,830 $10.85 $74K 240,754
2025-05-20 Lewis William Chair and CEO Sale 10b5-1 −2,863 $66.90 $192K 237,891
2025-05-20 Lewis William Chair and CEO Sale 10b5-1 −2,251 $68.13 $153K 235,640
2025-05-20 Lewis William Chair and CEO Sale 10b5-1 −1,716 $68.54 $118K 233,924
2025-05-20 Lewis William Chair and CEO Exercise or conversion · Stock Option (right to buy) 10b5-1 −6,830 163,990

Page 24 of 42 · 826 trades